These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 516860)

  • 21. Saphenous vein varicosities--the use of Tc-99m-RBC blood-pool imaging for evaluation and followup.
    Lubin E; Zelikovski A; Trumper J; Weininger J; Rechnic J; Urca I
    J Nucl Med; 1978 Sep; 19(9):1090-1. PubMed ID: 690718
    [No Abstract]   [Full Text] [Related]  

  • 22. [Experimental research on histological changes of the liver caused by injection on sclerosing solutions in the hepatic circulation].
    DOCIMO R; PELLEGRINI L
    G Ital Chir; 1956 Apr; 12(4):196-212. PubMed ID: 13344997
    [No Abstract]   [Full Text] [Related]  

  • 23. [A comparative study on the blood vessel sclerosing effect of pingyungmycin and Natrii morrhuates].
    Zhao J; Zhao Y; Chen X
    Hua Xi Kou Qiang Yi Xue Za Zhi; 1997 May; 15(2):97-8, 140. PubMed ID: 11480044
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Influence of a flavonol glycoside on unwanted sclerosing solution reactions].
    Mauss HJ
    Zentralbl Gynakol; 1971 Apr; 93(15):496-9. PubMed ID: 5576999
    [No Abstract]   [Full Text] [Related]  

  • 25. Mechanism of action of sclerotherapy.
    Green D
    Semin Dermatol; 1993 Jun; 12(2):88-97. PubMed ID: 8512799
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [STUDY OF CHANGES IN BLOOD COAGULATION IN THE COURSE OF MASSIVE SCLEROSING TREATMENTS].
    DOMART A; HODARA M; SAMAMA M; TESLER L
    Phlebologie; 1965; 18():73-7. PubMed ID: 14287545
    [No Abstract]   [Full Text] [Related]  

  • 27. In vitro effects of detergent sclerosants on clot formation and fibrinolysis.
    Parsi K; Exner T; Low J; Fung Ma DD; Joseph JE
    Eur J Vasc Endovasc Surg; 2011 Feb; 41(2):267-77. PubMed ID: 21183368
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Isotope methods in the diagnosis of venous disease. I. Methods of radionuclide venography (author's transl)].
    Endert G; Ritter H; Schumann E
    Rofo; 1979 Sep; 131(3):300-3. PubMed ID: 161266
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Venous diagnostics].
    Mantoni MY; Lund JO
    Ugeskr Laeger; 1997 Dec; 159(49):7297-301. PubMed ID: 9417728
    [No Abstract]   [Full Text] [Related]  

  • 30. Evaluation of the minimum effective concentration of foam sclerosant in an ex-vivo study.
    Erkin A; Kosemehmetoglu K; Diler MS; Koksal C
    Eur J Vasc Endovasc Surg; 2012 Dec; 44(6):593-7. PubMed ID: 23122185
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [An error too widely spread among the public, even among medical personnel: the risk of hypercoagulation caused by sclerosing solutions].
    Tournay R
    Phlebologie; 1977; 30(2):161-3. PubMed ID: 905335
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of a sclerosing solution on experimental wound healing in the rat.
    EL-KHASHAB MM
    J Dent Res; 1962; 41():800-7. PubMed ID: 14450529
    [No Abstract]   [Full Text] [Related]  

  • 33. Tumour promotion in mouse skin by sclerosing agents.
    SALAMAN MH; GLENDENNING OM
    Br J Cancer; 1957 Sep; 11(3):434-44. PubMed ID: 13499793
    [No Abstract]   [Full Text] [Related]  

  • 34. [Isotope methods in the diagnosis of venous disease. II. Results of radionuclide venography (author's transl)].
    Endert G; Ritter H; Schumann E
    Rofo; 1979 Sep; 131(3):304-8. PubMed ID: 161267
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Diagnosis and treatment of venous diseases].
    Santler R
    Wien Med Wochenschr; 1974 Oct; 124(42-43):607-10. PubMed ID: 4439954
    [No Abstract]   [Full Text] [Related]  

  • 36. [Treatment of varicose veins of the lower extremities with phlebosclerosing preparations].
    Liul'ka AN; Pereĭma FA
    Khirurgiia (Mosk); 1980 Apr; (4):88-91. PubMed ID: 7374089
    [No Abstract]   [Full Text] [Related]  

  • 37. [APROPOS OF THE WORK OF PROF. A. DOMART, DRS. M. HODARA, M. SAMAMA AND L. TESSLER ON CHANGES IN BLOOD COAGULATION IN THE COURSE OF MASSIVE SCLEROSING TREATMENTS].
    TOURNAY R
    Phlebologie; 1965; 18():79-80. PubMed ID: 14287546
    [No Abstract]   [Full Text] [Related]  

  • 38. [Coagulation level in sclerosing treatment of esophageal varices].
    Brunner G
    Dtsch Med Wochenschr; 1987 Oct; 112(40):1554. PubMed ID: 3652958
    [No Abstract]   [Full Text] [Related]  

  • 39. Effects of a sclerosing agent on odontogenesis.
    Mehlisch DR; Tolman DE
    Oral Surg Oral Med Oral Pathol; 1971 May; 31(5):723-30. PubMed ID: 4995488
    [No Abstract]   [Full Text] [Related]  

  • 40. Inhibition of tooth development with a sclerosing agent, sodium tetradecyl sulfate.
    Selinger LR; Archer WH; Thonard JC
    J Dent Res; 1966; 45(2):236-42. PubMed ID: 5220215
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.